Merck’s Research Chief Saved Biotech Deal With Juicy Pitch

After a bidding war for a stake in a promising experimental drug, Merck & Co. received a disappointing phone call. It had lost.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.